Common Cold Triggered Significant Rises in Thymosin Peptides and Immune Cells
Rhinovirus infection in healthy volunteers caused significant increases in thymosin alpha 1, beta 4, and multiple immune cell types by day 5 — confirmed in two independent groups.
Quick Facts
What This Study Found
Rhinovirus infection triggered significant increases in thymosin alpha 1 (p < 0.001), thymosin beta 4 (p < 0.001), and multiple immune cell types by day 5 after inoculation.
Key Numbers
How They Did This
Two groups of healthy volunteers were inoculated with rhinovirus. Blood was drawn at intervals. Thymosin levels were measured by RIA, and immune cell subsets were counted by flow cytometry.
Why This Research Matters
This was the first proof that a viral infection can trigger thymic hormone release. It shows thymosin alpha 1 is part of the body's early immune response to respiratory viruses.
The Bigger Picture
The thymic peptide response to even a common cold shows the immune system actively upregulates its peptide signaling during infection. This supports the role of thymosin peptides as real-time immune regulators.
What This Study Doesn't Tell Us
Volunteers were experimentally infected, which may not perfectly match natural colds. No placebo/uninfected control group described. The mechanism linking virus to thymosin release was not identified.
Questions This Raises
- ?Could exogenous thymosin alpha 1 speed cold recovery?
- ?Do people with higher baseline thymosin levels get fewer colds?
Trust & Context
- Key Stat:
- p < 0.001 for both peptides Thymosin alpha 1 and beta 4 significantly elevated by day 5 of rhinovirus infection
- Evidence Grade:
- Moderate — prospective study with experimental infection in two independent groups (RCT-level design).
- Study Age:
- Published in 1989 — one of the first studies tracking thymosin responses to controlled viral infection.
- Original Title:
- Modulation of thymosin alpha 1 and thymosin beta 4 levels and peripheral blood mononuclear cell subsets during experimental rhinovirus colds.
- Published In:
- Lymphokine research, 8(4), 383-91 (1989)
- Authors:
- Hsia, J, Sztein, M B(4), Naylor, P H(7), Simon, G L, Goldstein, A L, Hayden, F G
- Database ID:
- RPEP-00115
Evidence Hierarchy
Frequently Asked Questions
Why do thymosin levels rise during a cold?
The immune system needs more T-cells to fight the virus. Thymosin peptides help activate and mature these immune cells, so the body ramps up production in response to infection.
Could taking thymosin prevent colds?
This study shows thymosin naturally rises during infection. Whether pre-treatment could prevent or shorten colds has not been definitively tested, though thymosin alpha 1 is used clinically for immune support.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00115APA
Hsia, J; Sztein, M B; Naylor, P H; Simon, G L; Goldstein, A L; Hayden, F G. (1989). Modulation of thymosin alpha 1 and thymosin beta 4 levels and peripheral blood mononuclear cell subsets during experimental rhinovirus colds.. Lymphokine research, 8(4), 383-91.
MLA
Hsia, J, et al. "Modulation of thymosin alpha 1 and thymosin beta 4 levels and peripheral blood mononuclear cell subsets during experimental rhinovirus colds.." Lymphokine research, 1989.
RethinkPeptides
RethinkPeptides Research Database. "Modulation of thymosin alpha 1 and thymosin beta 4 levels an..." RPEP-00115. Retrieved from https://rethinkpeptides.com/research/hsia-1989-modulation-of-thymosin-alpha
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.